NOT-DA-14-032: Notice of Participation of the National Institute on Drug Abuse in PAR-14-315 "Testing Interventions for Health-Enhancing Physical Activity (R01)"

Notice of Participation of the National Institute on Drug Abuse in PAR-14-315 "Testing Interventions for Health-Enhancing Physical Activity (R01)"

Notice Number: NOT-DA-14-032

Key Dates
Release Date: August 26, 2014

Related Announcements
PAR-14-315

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants of the National Institute on Drug Abuse's participation, effective immediately, in PAR-14-315 "Testing Interventions for Health-Enhancing Physical Activity (R01)."

The following sections of PAR-14-315 have been updated to reflect the participation of NIDA in this FOA.

Part 1. Overview Information

Components of Participating Organizations
Division of Program Coordination, Planning and Strategic Initiatives, Office of
Disease Prevention (ODP)
National Cancer Institute (NCI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Behavioral and Social Sciences Research (OBSSR)
Office of Research on Women’s Health (ORWH)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.865; 93.866; 93.399; 93.273; 93.313; 93.279

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Lisa Onken, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-2235
Email: [email protected]

Financial/Grants Management Contact(s)

Diana Haikalis
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1373
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lisa Onken, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-2235
Email: [email protected]